Globe Newswire12.04.18
Milestone Scientific Inc., a developer of computerized drug delivery instruments that provide painless and precise injections, has signed an agreement with Clinical Technology Inc. (CTI), a specialty distributor of medical products in the mid-western region of the United States, for the CompuFlo Epidural System.
Kent Krafft, vice president of Clinical Technology Inc., stated, “We are impressed with Milestone Scientific’s CompuFlo Epidural System following extensive due diligence prior to entering this agreement. We have several instruments on loan with top anesthesiologists and have received positive feedback from both providers and patients, reinforcing our confidence in this disruptive technology. Knowing the precise location of a needle during an epidural procedure provides a measure of safety not available to medical professionals using conventional syringes that rely on subjective perception to identify the epidural space. We look forward to rolling out the CompuFlo Epidural System across the Midwest.”
Sharon Smith, executive vice president of Global Sales and Marketing of Milestone Scientific, commented, “We are pleased to partner with CTI in the Midwest. CTI will be an asset to Milestone as we aggressively educate medical professionals on the benefits of objective, quantifiable and real-time confirmation of accessing the epidural space and build a new standard of care with of the CompuFlo Epidural Instrument.”
Clinical Technology Inc., headquartered in Brecksville, Ohio, is a specialty distributor of medical products in the mid-western region of the United States. CTI operates directly in 13 states, is part of a national distribution alliance, and serves as master distributor capable of providing sales and distribution throughout the country. In addition, CTI maintains the infrastructure to facilitate a product from concept through the FDA approval process and into manufacturing and distribution.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic, and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology is the technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections.
Kent Krafft, vice president of Clinical Technology Inc., stated, “We are impressed with Milestone Scientific’s CompuFlo Epidural System following extensive due diligence prior to entering this agreement. We have several instruments on loan with top anesthesiologists and have received positive feedback from both providers and patients, reinforcing our confidence in this disruptive technology. Knowing the precise location of a needle during an epidural procedure provides a measure of safety not available to medical professionals using conventional syringes that rely on subjective perception to identify the epidural space. We look forward to rolling out the CompuFlo Epidural System across the Midwest.”
Sharon Smith, executive vice president of Global Sales and Marketing of Milestone Scientific, commented, “We are pleased to partner with CTI in the Midwest. CTI will be an asset to Milestone as we aggressively educate medical professionals on the benefits of objective, quantifiable and real-time confirmation of accessing the epidural space and build a new standard of care with of the CompuFlo Epidural Instrument.”
Clinical Technology Inc., headquartered in Brecksville, Ohio, is a specialty distributor of medical products in the mid-western region of the United States. CTI operates directly in 13 states, is part of a national distribution alliance, and serves as master distributor capable of providing sales and distribution throughout the country. In addition, CTI maintains the infrastructure to facilitate a product from concept through the FDA approval process and into manufacturing and distribution.
Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic, and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology is the technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections.
